These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6538503)

  • 21. Fatal paralytic ileus following vindesine chemotherapy in a patient with myeloma-associated amyloidosis.
    Kanoh T
    Eur J Haematol; 1989 Jan; 42(1):108. PubMed ID: 2914591
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of multiple myeloma in old patients. Finnish Leukaemia Group.
    Palva IP; Ahrenberg P; Ala-Harja K; Almqvist A; Hänninen A; Ilvonen M; Isomaa B; Jouppila J; Järvenpää E; Kilpi H
    Eur J Haematol; 1989 Oct; 43(4):328-31. PubMed ID: 2583258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical response.
    Maitland JA; Millar BC; Bell JB; Montes A; Treleaven J; Gore ME; McElwain TJ
    Br J Cancer; 1990 Mar; 61(3):429-33. PubMed ID: 2328211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.
    Ardizzoni A; Pronzato P; Canobbio L; Lionetto R; Rosso R
    J Cancer Res Clin Oncol; 1985; 110(1):77-8. PubMed ID: 4019571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in clonogenic tumour cells in bone marrow of patients with multiple myeloma treated with vincristine, doxorubicin, and methylprednisolone.
    Bell JB; Millar BC; Maitland JA; Nandi A; Gore M; McElwain TJ
    Lancet; 1988 Oct; 2(8617):931-3. PubMed ID: 2902382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
    Annunziata M; Celentano M; Pocali B; D'Amico MR; Palmieri S; Viola A; Copia C; Falco C; Del Vecchio L; Ferrara F
    Ann Hematol; 2006 Jun; 85(6):394-9. PubMed ID: 16538502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group.
    Palva IP; Ala-Harja K; Almqvist A; Elonen E; Hallman H; Hänninen A; Ilvonen M; Isomaa B; Jouppila J; Järvenpää E
    Eur J Haematol; 1993 Aug; 51(2):98-101. PubMed ID: 8370425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma. Finnish Leukaemia Group.
    Eur J Haematol; 1992 Jan; 48(1):37-40. PubMed ID: 1730278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.
    Aitchison RG; Reilly IA; Morgan AG; Russell NH
    Br J Cancer; 1990 May; 61(5):765-6. PubMed ID: 2337514
    [No Abstract]   [Full Text] [Related]  

  • 30. Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma.
    Sakalová A; Bock PR; Dedík L; Hanisch J; Schiess W; Gazová S; Chabronová I; Holomanova D; Mistrík M; Hrubisko M
    Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S38-44. PubMed ID: 11561871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of inflammatory breast cancer after neoadjuvant chemotherapy.
    Abrous-Anane S; Savignoni A; Daveau C; Pierga JY; Gautier C; Reyal F; Dendale R; Campana F; Kirova YM; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1055-63. PubMed ID: 20478662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin, etoposide, and vindesine interactions.
    Ward K; Bitran JD
    Cancer Treat Rep; 1984 May; 68(5):817-8. PubMed ID: 6539172
    [No Abstract]   [Full Text] [Related]  

  • 33. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
    von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
    Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
    [No Abstract]   [Full Text] [Related]  

  • 35. [Decrease of paraprotein secretion despite progressive tumor cell proliferation by cytostatic drug therapy of plasmacytoma].
    Zurborn KH; Sondermann I; Gross WL
    Internist (Berl); 1985 Sep; 26(9):584-6. PubMed ID: 3905684
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
    Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
    Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory and relapsing multiple myeloma treated by blood stem cell transplantation.
    Gertz MA; Pineda AA; Chen MG; Letendre L; Greipp PR; Solberg LA; Witzig TE; Garton JP; Inwards DJ; Litzow MR
    Am J Med Sci; 1995 Mar; 309(3):152-61. PubMed ID: 7879820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
    Pavlovsky S; Saslavsky J; Tezanos Pinto M; Palmer L; Curuchet M; Lein JM; Garay G; Dragosky M; Quiroga-Micheo E; Huberman AB
    J Clin Oncol; 1984 Jul; 2(7):836-40. PubMed ID: 6376722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.
    Fiore JJ; Kelsen DP; Gralla RJ; Casper ES; Magill G; Cheng E; Ochoa M
    Cancer Treat Rep; 1985 Jun; 69(6):591-4. PubMed ID: 4016765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
    Straus DJ; Myers J; Koziner B; Lee BJ; Clarkson BD
    Cancer Chemother Pharmacol; 1983; 11(2):80-5. PubMed ID: 6194913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.